Project Grant R15GM144930

Award Date 1/1/22
Completion Date 7/31/23
Dollars Obligated $601K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Sioux Center, IA 51250, USA
Similar Awards
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), aims to synthesize a comprehensive library of 38 structurally defined sulfated O-GalNAc glycans. The $290,986 award to Chembind LLC will utilize a Sulfated Modular Synthesis/Enzymatic Assembly (SMSEA) approach to create these glycans, which are critical for advancing the understanding of their biological functions in human health...
The National Institute of General Medical Sciences (NIGMS) awarded a $357,646 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Mississippi. This 5-year grant, effective July 1, 2024, supports the Zhu Lab's research to develop a generalized strategy for synthesizing libraries of sulfoglycopeptides - complex molecules with co-localized tyrosine sulfation and O-glycosylation. The project aims to map the relationship between these...
This $350,000 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports the development of an artificial intelligence (AI)-based platform for peptide lead optimization. The platform will enable researchers to model the potency, solubility, stability, and permeability of peptides, including those containing non-canonical amino acids and cyclic structures. The goal is to expedite peptide...
This $213,563 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) aims to develop a new class of "shape-shifting" cyclic peptide molecules with polypharmacological properties. The University of Colorado, as the prime awardee, will leverage combinatorial solid phase peptide synthesis to create a dynamic library of synthetic "bullvalene amino acid" containing cyclic...
The National Institutes of Health National Institute of General Medical Sciences awarded a $903,000 Project Grant to The University of Toledo to develop new glycosylation methods for microbial glycan synthesis under the Biomedical Research and Research Training program (CFDA 93.859). Over a three-year period from September 2022 to August 2025, the University will create two new catalytic glycosylation methodologies - a cationic gold(I)-catalyzed glycosylation using glycosyl...
The National Institute of General Medical Sciences (NIGMS) awarded Biocognon LLC a Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) in the amount of $303,024 to develop an innovative combinatorial pipeline for discovering anti-GPCR nanobodies. The project aims to overcome limitations in current antibody discovery platforms by leveraging Biocognon's yeast dual biosensor technology to enable screening of multiple GPCR targets simultaneously without...
This $445,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports research conducted by the Beckman Research Institute of the City of Hope. The core objectives of this 5-year project are to: Dissect the structural basis of allosteric modulation by the third intracellular loop (ICL3) of G protein-coupled receptors (GPCRs) and define its roles in autoregulation and G protein...
This $249,986 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) will fund the acquisition of a CEM Liberty Prime 2.0 HT12 microwave-assisted peptide synthesizer. The instrument will enable the efficient and cost-effective synthesis of peptidomimetics, peptide-based biosensors, and small enzymes for the grantee's research projects focused on developing novel therapeutic candidates and...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) program, CFDA 93.859 Biomedical Research and Research Training, provides $1,640,169 to Synvivia, Inc. to validate a platform for identifying cyclic peptides that increase the yield and quality of adeno-associated virus (AAV) vectors manufactured for gene therapy. The goal is to overcome challenges related to the scalability, yield, and quality of current AAV vector manufacturing processes, which...
The National Institute of General Medical Sciences (NIGMS) awarded a $360,100 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of California, Berkeley. This funding supports the development of novel synthetic methods for pharmaceutical production through the use of supramolecular catalysis. Specifically, the project aims to leverage supramolecular hosts and coencapsulation techniques to enable transformations relevant to the production...

CHEMOENZYMATIC SYNTHESIS OF GLYCOSYLATED AND SULFATED CCR5 N-TERMINAL PEPTIDE LIBRARY - CO-LOCALIZATION OF TYROSINE (TYR) SULFATION AND O-GLYCOSYLATION (CSOG) IS AN EMERGING GLOBAL PATTERN OF POST-TRANSLATIONAL MODIFICATIONS (PTMS). CSOG IS THE MAJOR PTM PATTERN ON THE N- TERMINAL PEPTIDE OF CC CHEMOKINE RECEPTOR 5 (CCR5). CCR5 IS INVOLVED IN CRITICAL HUMAN DISEASES SUCH AS CANCERS AND INFLAMMATORY DISEASES, AND THE N-TERMINAL PEPTIDE OF CCR5 IS ESSENTIAL FOR THE BINDING BETWEEN CCR5 AND ITS LIGANDS. THE ACCESS TO SULFATED AND GLYCOSYLATED N-TERMINAL PEPTIDES OF CCR5 (CCR5-SGNTPS) AND ANY OTHER PEPTIDES WITH CSOG IS HINDERED BY DIVERSIFIED PATTERNS OF GLYCOSYLATION AND SULFATION, LABILITY OF SULFATION, AND COMPLEX SUGAR STRUCTURES. THIS PROPOSAL AIMS TO DEVELOP EFFICIENT CHEMOENZYMATIC METHODS FOR SYNTHESIZING GLYCOPEPTIDES CONTAINING O-GLYCANS AND TYR SULFATION. THEREFORE, WE ARE AIMING TO EFFICIENTLY SYNTHESIZE CCR5-SGNTPS TO BUILD UP THE ACCESS TO CCR5-SGNTPS AND FURTHER PROVIDE NEW CLUES FOR RELATED BIOMEDICAL RESEARCH. LABILITY OF SULFATE GROUP DURING SYNTHESIS AND COMPLEXITY OF SUGAR STRUCTURES ARE THE MAJOR OBSTACLES TO THE ACHIEVEMENT OF THE LIBRARY OF CCR5-SGNTPS. WE PROVIDE A NOVEL AND EFFICIENT CHEMOENZYMATIC APPROACH, MERGING TWO WELL- STUDIED SYNTHETIC METHODOLOGIES TO OVERCOME THE OBSTACLES. ONE OF THE TWO METHODOLOGIES IS SOLID-PHASE SITE-SELECTIVE SULFATION, AND THE OTHER ONE IS CHEMOENZYMATIC SYNTHESIS OF GLYCOPEPTIDES. SITE-SELECTIVE SULFATION WITH DIVERGENTLY PROTECTED TYRS CAN EFFICIENTLY BUILD DIVERSIFIED SULFATION PATTERNS, AND CHEMOENZYMATIC SYNTHESIS OF GLYCOPEPTIDES CAN SYNTHESIZE GLYCOPEPTIDES WITH COMPLEX SUGAR STRUCTURES IN HIGH REGIO- AND STEREO-SELECTIVITY WITH HIGH FIDELITY. NOTABLY, THE MILD CONDITIONS (SLIGHTLY BASIC) OF GLYCOSYLTRANSFERASES CATALYZED REACTIONS ARE IDEAL FOR KEEPING THE INTEGRITY OF THE LABILE SULFATE GROUP. GLYCOSYLATED-AMINO ACIDS (GAAS) WITH CORE SUGARS AND FMOC-TYRS WITH DIVERGENT PROTECTING GROUPS CAN BE SYNTHESIZED EFFICIENTLY WITH CURRENT SYNTHETIC METHODOLOGIES. THEN THE TWO CLASSES OF BUILDING BLOCKS WILL BE SELECTIVELY INCORPORATED INTO SOLID PHASE PEPTIDE SYNTHESIS (SPPS) TO OBTAIN PROTECTED SULFATED AND GLYCOSYLATED PEPTIDES. AFTER REMOVAL OF PROTECTING GROUPS, GLYCOSYLTRANSFERASES WILL BE USED TO EXTEND THE CORE SUGARS TO GENERATE LARGER AND MORE COMPLEX GLYCOPEPTIDES FOLLOWING BIOSYNTHETIC PATHWAYS. AFTER BINDING STUDY OF THE SYNTHESIZED LIBRARY, DETAILED INFORMATION ABOUT HOW THE TWO PTMS CO-REGULATE BINDING PROCESSES WILL BE OBTAINED. MOREOVER, A PEPTIDE LIBRARY WITH STRUCTURE-DEFINED CCR5-SGNTPS WILL PROVIDE STANDARDS FOR PROTEOMICS AND GLYCOMICS RESEARCH OF CCR5-SGNTPS.

Posted 12/17/21, 12:00 AM